Inverse relation between intensity of GFAP expression in the substantia gelatinosa and degree of chronic mechanical allodynia

Neuroscience Letters

Volumn 452, Issue 2, 2009, Pages 101-105

  Deumens, Ronald ^a   Jaken, Robby J P ^a   Knaepen, Liesbeth ^a   van der Meulen, Inge ^b   Joosten, Elbert A J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Central sensitization; Dorsal horn; Glia; Nerve injury; Pain; Plasticity; Spinal cord

Indexed keywords

COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; GLIAL FIBRILLARY ACIDIC PROTEIN; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CELL FUNCTION; CHRONIC PAIN; CONTROLLED STUDY; MACROGLIA; MALE; MICROGLIA; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SUBSTANTIA GELATINOSA; UPREGULATION;

ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROGLIA; PAIN, INTRACTABLE; POSTERIOR HORN CELLS; RATS; RATS, WISTAR; RECEPTORS, COMPLEMENT; SCIATIC NEUROPATHY; SUBSTANTIA GELATINOSA; UP-REGULATION;

EID: 60249093381     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.12.062     Document Type: Article

References (47)

1. Bettoni I., Comelli F., Rossini C., Granucci F., Giagnoni G., Peri F., and Costa B. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 56 (2008) 1312-1319
2. Coggeshall R.E., Lekan H.A., White F.A., and Woolf C.J. A-fiber sensory input induces neuronal cell death in the dorsal horn of the adult rat spinal cord. J. Comp. Neurol. 435 (2001) 276-282
3. Colburn R.W., Rickman A.J., and DeLeo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol. 157 (1999) 289-304
4. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., and De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 (2005) 1017-1021
5. Coyle D.E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23 (1998) 75-83
6. Davies J.E., Proschel C., Zhang N., Noble M., Mayer-Proschel M., and Davies S.J. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J. Biol. 7 (2008) 24
7. Decosterd I., and Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87 (2000) 149-158
8. Deumens R., Jaken R.J., Marcus M.A., and Joosten E.A. The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection. J. Neurosci. Methods 164 (2007) 120-130
9. Dowdall T., Robinson I., and Meert T.F. Comparison of five different rat models of peripheral nerve injury. Pharmacol. Biochem. Behav. 80 (2005) 93-108
10. Farquhar-Smith W.P., Egertova M., Bradbury E.J., McMahon S.B., Rice A.S., and Elphick M.R. Cannabinoid CB(1) receptor expression in rat spinal cord. Mol. Cell. Neurosci. 15 (2000) 510-521
11. Garrison C.J., Dougherty P.M., and Carlton S.M. GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801. Exp. Neurol. 129 (1994) 237-243
12. Garrison C.J., Dougherty P.M., Kajander K.C., and Carlton S.M. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res. 565 (1991) 1-7
13. Hofstetter C.P., Holmstrom N.A., Lilja J.A., Schweinhardt P., Hao J., Spenger C., Wiesenfeld-Hallin Z., Kurpad S.N., Frisen J., and Olson L. Allodynia limits the usefulness of intraspinal neural stem cell grafts: directed differentiation improves outcome. Nat. Neurosci. 8 (2005) 346-353
14. Hohmann A.G., and Suplita II R.L. Endocannabinoid mechanisms of pain modulation. AAPS J. 8 (2006) E693-E708
15. Ji R.R., Kawasaki Y., Zhuang Z.Y., Wen Y.R., and Decosterd I. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol. 2 (2006) 259-269
16. Jin S.X., Zhuang Z.Y., Woolf C.J., and Ji R.R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23 (2003) 4017-4022
17. Katsura H., Obata K., Miyoshi K., Kondo T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Sakagami M., and Noguchi K. Transforming growth factor-activated kinase 1 induced in spinal astrocytes contributes to mechanical hypersensitivity after nerve injury. Glia 56 (2008) 723-733
18. Kelly S., and Chapman V. Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J. Neurophysiol. 86 (2001) 3061-3064
19. Kozai T., Yamanaka H., Dai Y., Obata K., Kobayashi K., Mashimo T., and Noguchi K. Tissue type plasminogen activator induced in rat dorsal horn astrocytes contributes to mechanical hypersensitivity following dorsal root injury. Glia 55 (2007) 595-603
20. Kuzumaki N., Narita M., Narita M., Hareyama N., Niikura K., Nagumo Y., Nozaki H., Amano T., and Suzuki T. Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial differentiation from neural stem cells in mice. Neurosci. Lett. 415 (2007) 22-27
21. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6 (2005) 521-532
22. McCleane G. Pharmacological management of neuropathic pain. CNS Drugs 17 (2003) 1031-1043
23. McMahon S.B., Cafferty W.B., and Marchand F. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192 (2005) 444-462
24. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., Tracey K., Martin D., Maier S.F., and Watkins L.R. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 23 (2003) 1026-1040
25. Molander C., and Grant G. Spinal cord cytoarchitecture. In: Paxinos G. (Ed). The Rat Nervous System. second ed. (1995), Academic Press, San Diego 39-45
26. Murray M., Wang S.D., Goldberger M.E., and Levitt P. Modification of astrocytes in the spinal cord following dorsal root or peripheral nerve lesions. Exp. Neurol. 110 (1990) 248-257
27. Obata K., Katsura H., Miyoshi K., Kondo T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Akira S., and Noguchi K. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J. Neurochem. (2008)
28. Raghavendra V., Tanga F., and DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306 (2003) 624-630
29. Romero-Sandoval A., Chai N., Nutile-McMenemy N., and Deleo J.A. A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res. 1219 (2008) 116-126
30. Salio C., Fischer J., Franzoni M.F., and Conrath M. Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Neuroscience 110 (2002) 755-764
31. Scholz J., and Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10 (2007) 1361-1368
32. Seltzer Z., Dubner R., and Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 (1990) 205-218
33. Smits H., Ultenius C., Deumens R., Koopmans G.C., Honig W.M., van Kleef M., Linderoth B., and Joosten E.A. Effect of spinal cord stimulation in an animal model of neuropathic pain relates to degree of tactile "allodynia". Neuroscience 143 (2006) 541-546
34. Tanga F.Y., Raghavendra V., and DeLeo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem. Int. 45 (2004) 397-407
35. Tilleux S., Berger J., and Hermans E. Induction of astrogliosis by activated microglia is associated with a down-regulation of metabotropic glutamate receptor 5. J. Neuroimmunol. 189 (2007) 23-30
36. Tozaki-Saitoh H., Tsuda M., Miyata H., Ueda K., Kohsaka S., and Inoue K. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci. 28 (2008) 4949-4956
37. Tsuda M., Inoue K., and Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci. 28 (2005) 101-107
38. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., and Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
39. Wall P.D., Devor M., Inbal R., Scadding J.W., Schonfeld D., Seltzer Z., and Tomkiewicz M.M. Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa. Pain 7 (1979) 103-111
40. Walter L., Franklin A., Witting A., Moller T., and Stella N. Astrocytes in culture produce anandamide and other acylethanolamides. J. Biol. Chem. 277 (2002) 20869-20876
41. Walter L., and Stella N. Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes. Glia 44 (2003) 85-90
42. Watkins L.R., and Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev. 82 (2002) 981-1011
43. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2 (2003) 973-985
44. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 24 (2001) 450-455
45. Zhang J., and De Koninck Y. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J. Neurochem. 97 (2006) 772-783
46. Zhuang Z.Y., Gerner P., Woolf C.J., and Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114 (2005) 149-159
47. Zhuang Z.Y., Wen Y.R., Zhang D.R., Borsello T., Bonny C., Strichartz G.R., Decosterd I., and Ji R.R. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 26 (2006) 3551-3560